摘要
证据分级和推荐强度判定是循证指南制定的关键环节,近些年有了长足的发展和进步。该文系统回顾了近30年国内外证据分级和推荐强度的发展与演进,并对主要代表性标准进行了介绍,同时对我国神经疾病领域发表的指南和共识规范性的评价结果进行了简要介绍,提出了今后的改进之处,以期让读者了解证据分级和推荐强度的发展规律,以便更好地阅读和理解指南,以及更加规范地制定指南。
Evidence grading and recommendation strength assessment are key steps in the development of evidence-based guidelines,and have made significant progress in recent years.This article systematically reviews the development and evolution of evidence grading and recommendation strength in the past 30 years,and introduces the main representative standards.At the same time,a brief introduction is given to the guidelines and consensus evaluation results published in the field of neurological diseases in China,and future improvements are proposed.This article aims to help readers understand the development patterns of evidence grading and recommendation strength,in order to better understand the guidelines,and to develop more standardized guidelines.
作者
张丁丁
朱以诚
ZHANG Dingding;ZHU Yicheng(Department of Neurology,Peking Union Medical College Hospital,Beijing 100730,P.R.China)
出处
《华西医学》
CAS
2024年第5期677-680,共4页
West China Medical Journal
基金
北京协和医院中央高水平医院临床科研专项(2022-PUMCH-A-025)。
关键词
循证指南
证据分级
推荐强度
Evidence-based guidelines
evidence grading
recommendation strength